Cardiac Evaluation as Part of the Initial Extension Studies in Neuroendocrine Tumors. Experience in a Multidisciplinary Team. ARGENTUM GROUP

#1157

Introduction: Carcinoid heart disease (CHD) is a complication of metastatic neuroendocrine tumors and is screened for using echocardiography. Published case series showed that when cardiological evaluation is done at least 50% of the patients have CHD, and 33% had surgical indication.

Aim(s): To describe clinical cardiological visit and echocardiographic assessment as a screening at the time of diagnosis of carcinoid syndrome (CS) in our Group.

Materials and methods: 28 patients were referred to the Department of cardio-oncology at the diagnosis of carcinoid syndrome (CS) for a prospective evaluation. Population characteristics were described. The endpoint was time to surgical indication and the differences between causes of A) dead during follow up and B) alive during follow up. Cardiac involvement was evaluated by clinical symptoms and echocardiographic findings.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: santos_chacon@ciudad.com.ar D

Authors: Santos D, O'Connor J, Pesce V, Bestani C, Belli S,

Keywords: Cardiac heart disease, neuroendocrine tumors,

To read the full abstract, please log into your ENETS Member account.